Rebekka Mispelbaum

Bonn, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Prognosis and aetiology of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in patients with active lung or lower head and neck cancer (PEPP-C): a retrospective, matched multicentre cohort study in Germany and Spain.

Prognosis and aetiology of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in patients with active lung or lower head and neck cancer (PEPP-C): a retrospective, matched multicentre cohort study in Germany and Spain.

Journal: Infection

Published: March 30, 2026

Longer time to response in hemato-oncological patients with immune thrombocytopenia (ITP): a pilot study.

Longer time to response in hemato-oncological patients with immune thrombocytopenia (ITP): a pilot study.

Journal: Expert review of hematology

Published: March 11, 2026

Clinical efficacy and immunological aspects of neoadjuvant and perioperative therapy in resectable head and neck carcinoma.

Clinical efficacy and immunological aspects of neoadjuvant and perioperative therapy in resectable head and neck carcinoma.

Journal: Cancer treatment reviews

Published: March 02, 2026

CD103+ tissue-resident T-cells in head and neck squamous cell carcinomas of patients treated anti-PD-1 therapy.

CD103+ tissue-resident T-cells in head and neck squamous cell carcinomas of patients treated anti-PD-1 therapy.

Journal: Cancer treatment and research communications

Published: October 21, 2025

Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology.

Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology.

Journal: The Lancet. Oncology

Published: October 21, 2025

Effective and safe use of immune checkpoint inhibitors for non-small cell lung cancer in people living with HIV.

Effective and safe use of immune checkpoint inhibitors for non-small cell lung cancer in people living with HIV.

Journal: HIV medicine

Published: July 30, 2025

On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information.

On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information.

Journal: Frontiers in immunology

Published: March 24, 2025

Retrospective analysis of 300 microbial cell-free DNA sequencing results in routine blood stream infection diagnostics.

Retrospective analysis of 300 microbial cell-free DNA sequencing results in routine blood stream infection diagnostics.

Journal: Frontiers in cellular and infection microbiology

Published: September 30, 2024

Respiratory syncytial virus infection in patients with haematological diseases: a retrospective multicentre study.

Respiratory syncytial virus infection in patients with haematological diseases: a retrospective multicentre study.

Journal: Infection

Published: September 28, 2024

2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies.

2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies.

Journal: The Lancet regional health. Europe

Published: July 19, 2024

Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden.

Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden.

Journal: Frontiers in oncology

Published: March 25, 2024

Safety and efficacy of helical tomotherapy following lung-sparing surgery in locally advanced malignant pleural mesothelioma.

Safety and efficacy of helical tomotherapy following lung-sparing surgery in locally advanced malignant pleural mesothelioma.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: August 14, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026